太龙药业：新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务

每日经济新闻2023-03-03

每经AI快讯，有投资者在投资者互动平台提问：请问公司中药CRO业务目前开展情况如何？有何优势？子公司新领先去年大幅扩招研发人员的原因是什么？太龙药业（600222.SH）3月3日在投资者互动平台表示，新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务，同时开展部分中药项目研究储备。近年来新领先持续加强研发技术人才储备和培养，以加快推进各地药物研发服务平台和研究分院的建设，完善...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2316744942?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-03-03 16:19","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2316744942","market":"sh","top_or_hot":-1,"title":"太龙药业：新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，有投资者在投资者互动平台提问：请问公司中药CRO业务目前开展情况如何？有何优势？子公司新领先去年大幅扩招研发人员的原因是什么？太龙药业（600222.SH）3月3日在投资者互动平台表示，新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务，同时开展部分中药项目研究储备。近年来新领先持续加强研发技术人才储备和培养，以加快推进各地药物研发服务平台和研究分院的建设 ，完善...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303031620568415907f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>太龙药业：新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n太龙药业：新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-03 16:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303031620568415907f&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，有投资者在投资者互动平台提问：请问公司中药CRO业务目前开展情况如何？有何优势？子公司新领先去年大幅扩招研发人员的原因是什么？太龙药业（600222.SH）3月3日在投资者互动平台表示，新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务，同时开展部分中药项目研究储备。近年来新领先持续加强研发技术人才储备和培养，以加快推进各地药物研发服务平台和研究分院的建设 ，完善...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303031620568415907f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303031620568415907f&s=b","article_id":"2316744942","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303031620568415907f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2316744942","pubTimestamp":1677831599,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"每经AI快讯，有投资者在投资者互动平台提问：请问公司中药CRO业务目前开展情况如何？有何优势？子公司新领先去年大幅扩招研发人员的原因是什么？太龙药业（600222.SH）3月3日在投资者互动平台表示，新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务，同时开展部分中药项目研究储备。近年来新领先持续加强研发技术人才储备和培养，以加快推进各地药物研发服务平台和研究分院的建设 ，完善CXO全产业链服务体系。(记者 尹华禄)","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600222":"太龙药业","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"Tailong Pharmaceutical: The new leader relies on the research and development foundation and advantages of the parent company's traditional Chinese medicine to provide CRO services of traditional Chinese medicine according to customer needs","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600222":0.9},"content_text":"每经AI快讯，有投资者在投资者互动平台提问：请问公司中药CRO业务目前开展情况如何？有何优势？子公司新领先去年大幅扩招研发人员的原因是什么？太龙药业（600222.SH）3月3日在投资者互动平台表示，新领先依托母公司中药研发基础和优势，根据客户需求提供中药CRO服务，同时开展部分中药项目研究储备。近年来新领先持续加强研发技术人才储备和培养，以加快推进各地药物研发服务平台和研究分院的建设 ，完善CXO全产业链服务体系。(记者 尹华禄)","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2316744942"}